Methyllycaconitine citrate (MLA)

CO[C@@H]1C (C (N (CC) C2) C3 (O) [C@H]4OC) ([C@@] (C[C@@]5 ([H]) [C@@H]6OC) ([H]) [C@@]6 ([H]) [C@@]3 (C[C@@H]5OC) O) [C@@]4 ([H]) [C@@]2 (COC (C7=C (N (C8=O) C (C[C@@H]8C) =O) C=CC=C7) =O) CC1.O=C (CC (C (O) =O) (O) CC (O) =O) O

Methyllycaconitine citrate (MLA) is the citrate salt of Methyllycaconitine, a norditerpenoid alkaloid isolated from Delphinium brownii seeds. It acts as a selective antagonist of the α7 neuronal nicotinic acetylcholine receptor (α7nAChR) and exhibits potential as a drug candidate for Alzheimer’s disease treatment.